Net profit of Brawn Biotech rose 25.00% to Rs 0.05 crore in the quarter ended March 2012 as against Rs 0.04 crore during the previous quarter ended March 2011. Sales declined 9.54% to Rs 2.94 crore in the quarter ended March 2012 as against Rs 3.25 crore during the previous quarter ended March 2011.
For the unaudited full year, net profit declined 19.05% to Rs 0.17 crore in the year ended March 2012 as against Rs 0.21 crore during the previous year ended March 2011. Sales declined 8.93% to Rs 14.68 crore in the year ended March 2012 as against Rs 16.12 crore during the previous year ended March 2011.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2012 | Mar. 2011 | % Var. | Mar. 2012 | Mar. 2011 | % Var. |
| Sales | 2.94 | 3.25 | -10 | 14.68 | 16.12 | -9 |
| OPM % | 1.70 | 1.23 | 38 | 1.36 | 2.48 | -45 |
| PBDT | 0.05 | 0.04 | 25 | 0.21 | 0.41 | -49 |
| PBT | 0.05 | 0.04 | 25 | 0.20 | 0.41 | -51 |
| NP | 0.05 | 0.04 | 25 | 0.17 | 0.21 | -19 |